“Moving forward, cancer may not be a death threat but a manageable disease with strong control”

Could you explain more about the advantages of using iPSCs from cord blood for creating your ‘off-the-shelf’...

October 31, 2024 | Thursday | Opinion
Avance Clinical Strengthens Asia-Pacific Presence with Strategic MoUs in South Korea for Enhanced Clinical Research Solutions

Avance Clinical, a leading full-service Contract Research Organization (CRO), has announced three pivotal Memorandums of...

October 30, 2024 | Wednesday | News
Australia's Vaxxas licenses next-gen vaccine for Respiratory Syncytial Virus from NIH

Australia-based Vaxxas, a clinical-stage biotechnology company commercialising a novel high-density microarray patc...

October 29, 2024 | Tuesday | News
Seaport Therapeutics secures $225 M funding to develop neuropsychiatric medicines using prodrug technology

The clinical-stage biopharmaceutical company, Seaport Therapeutics, which uses a unique drug delivery platform orig...

October 26, 2024 | Saturday | News
Australia's Telix spins off Rhine Pharma to expand global access to radiopharmaceuticals

Australia-based Telix Pharmaceuticals has announced the spin-off of Rhine Pharma, which has the mission of expanding glo...

October 23, 2024 | Wednesday | News
Aidoc and Integral Diagnostics expand AI partnership in Australia and New Zealand

Aidoc, a global pioneer in clinical artificial intelligence (AI) solutions, has announced the expansion of its partnersh...

October 15, 2024 | Tuesday | News
Australian partnership working towards Universal Health in the Philippines

University of Adelaide’s Joanna Briggs Institute (JBI) is working with the Australia Awards Fellowships to he...

October 12, 2024 | Saturday | News
$18 M investment for world-first Australian research project for heart attack protection

The government is investing almost $18 million in a world-first Australian research project that will trial a drug disco...

October 7, 2024 | Monday | News
Indian medtech firm SMT gets Australian approval for drug-eluting stent Supraflex Cruz

SMT (Sahajanand Medical Technologies), a global leader in innovative medical devices based in India, has announced that ...

September 28, 2024 | Saturday | News
Australia's Telix Pharma buys RLS (USA) for $230 M to build next gen radiometal production network

Australia-headquartered Telix Pharmaceuticals and RLS (USA) Inc., America's only Joint Commission-accredited radiopharma...

September 23, 2024 | Monday | News
India-Australia partnership to build bio innovation corridor

La Trobe University, Australia and India’s Biotechnology Industry Research Assistance Council (BIRAC) have signed ...

September 20, 2024 | Friday | News
University of Melbourne launches Global Centre in Delhi, India

The Premier of Victoria, Jacinta Allan recently opened the University of Melbourne’s first Melbourne Global Centre...

September 18, 2024 | Wednesday | News
See-Mode Technologies gets US FDA clearance for thyroid ultrasound AI analysis and reporting software

Australia-based startup See-Mode Technologies, a global innovator in artificial intelligence (AI) for ultrasound imaging...

September 17, 2024 | Tuesday | News
Australia-Germany partnership of AUD $54 M to fund groundbreaking research into early immunity

The Cumming Global Centre for Pandemic Therapeutics in Melbourne, Australia and the University of Bonn in Germany, have ...

September 16, 2024 | Monday | News
Australia's IonOpticks responds to growing global market needs for proteomics tools by partnering with Nordic private equity firm

Australia-based IonOpticks, a leading global producer of high-performance chromatography columns, has announced its...

September 11, 2024 | Wednesday | News
Sydney Infectious Diseases Institute strengthens ties in India

The University of Sydney's $100,000 commitment towards research with the Public Health Foundation of India will allow ...

September 10, 2024 | Tuesday | News
Australia's biotech firm CSL sells plasma collection and fractionation operations in China for $185 M

Australia-based biotechnology company CSL Limited has entered into an agreement with Chengdu Rongsheng Pharmaceuti...

September 6, 2024 | Friday | News
University of Sydney receives $6 M funding to run two new Centres of Research Excellence, to address TB and mental health

Australia's University of Sydney researchers will lead two new national medical research centres focused on the elimin...

September 4, 2024 | Wednesday | News